Raymond James Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $682K | Sell |
|
|||||
|
2024
Q2 | $3.04M | Buy |
|
|||||
|
2024
Q1 | $3.57M | Buy |
|
|||||
|
2023
Q4 | $2.74M | Buy |
|
|||||
|
2023
Q3 | $476K | Sell |
|
|||||
|
2023
Q2 | $753K | Buy |
|
|||||
|
2023
Q1 | $539K | Sell |
|
|||||
|
2022
Q4 | $562K | Sell |
|
|||||
|
2022
Q3 | $449K | Sell |
|
|||||
|
2022
Q2 | $435K | Sell |
|
|||||
|
2022
Q1 | $1.14M | Buy |
|
|||||
|
2021
Q4 | $1.16M | Sell |
|
|||||
|
2021
Q3 | $1.21M | Buy |
|
|||||
|
2021
Q2 | $928K | Buy |
|
|||||
|
2021
Q1 | $227K | Sell |
|
|||||
|
2020
Q4 | $235K | Buy |
|
|||||
|
2020
Q3 | $257K | Sell |
|
|||||
|
2020
Q2 | $264K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $203K | Buy |
|